Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 4/20 | 0.44 |
| ▸ | GSK3B | P49841 | 4/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13121201 | 0.90 | CDK2 (0.58) | CDK2GSK3BCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL13289141 | 0.89 | CDK2 (0.53) | CDK2GSK3BSMN1; SMN2RAB9A | |
| SCHEMBL13289429 | 0.88 | CDK2 (0.49) | CDK2GSK3BSMN1; SMN2RAB9A | |
| SCHEMBL14546009 | 0.86 | CDK2 (0.46) | CDK2GSK3BCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL13289126 | 0.86 | GSK3B (0.47) | CDK2GSK3BCYP2D6CYP2C19POLB | |
| SCHEMBL13289547 | 0.86 | CDK2 (0.46) | CDK2GSK3BSMN1; SMN2 | |
| SCHEMBL13289385 | 0.85 | GSK3B (0.47) | CDK2GSK3BCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL13121122 | 0.84 | CDK2 (0.56) | CDK2GSK3BCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL13121043 | 0.84 | CDK2 (0.56) | CDK2GSK3BCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL13289297 | 0.84 | CDK2 (0.44) | CDK2GSK3BCYP2D6CYP2C19POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194058-A1 | Pyrazolopyrimidines suitable for the treatment of cancer diseases | SCHERING CORPORATION (US) | 2010-06-09 | — | — | EP | disclosed |